Avalo Therapeutics (AVTX) Return on Capital Employed Growth (1y) (2016 - 2026)
Avalo Therapeutics (AVTX) Return on Capital Employed Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 2,400.00 |
| 10 | Avalo Therapeutics | 397.51 Mn | 340.36 Mn | - | -4,570.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,570.00 |
| Dec 31, 2025 | -938.00 |
| Sep 30, 2025 | 9,078.00 |
| Jun 30, 2025 | 22,516.00 |
| Mar 31, 2025 | -7,207.00 |
| Dec 31, 2024 | 7,508.00 |
| Sep 30, 2024 | -960.00 |
| Jun 30, 2024 | -789.00 |
| Mar 31, 2024 | 25,543.00 |
| Dec 31, 2023 | 15,820.00 |
| Sep 30, 2023 | 14,910.00 |
| Jun 30, 2023 | -5,414.00 |
| Mar 31, 2023 | -8,343.00 |
| Dec 31, 2022 | -17,056.00 |
| Sep 30, 2022 | -15,402.00 |
| Jun 30, 2022 | -2,799.00 |
| Mar 31, 2022 | 12,864.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | -201.00 |
| Jun 30, 2021 | -6,076.00 |